Dihydroartemisinin was converted to its corresponding alkyne-functionalized esters, which were subsequently deployed as substrates for a 'click' chemistrymediated coupling with 3'-azido-3'-deoxythydimine (AZT) to furnish novel triazole-artesunate-AZT hybrid compounds. Moreover, various substituted triazole-artemisinin hybrids were synthesized based on 'click' chemistry between propargyl-substituted derivatives and artemisinin containing a 2-hydroxypropane unit. Fourteen new hybrids were thus successfully prepared and evaluated as cytotoxic agents, revealing an interesting anticancer activity of four triazole-artemisinin derivative hybrids in KB and HepG2 cancer cell lines.
Artemisinin, a natural sesquiterpene lactone, isolated from wormwood (Artemisia annua L.), and its derivatives dihydroartemisinin (DHA), artemether, arteether and artesunate have been used as important lead compounds for antimalarial drug development [1] . In addition to their well-known antimalarial activity, artemisinin derivatives were found to possess several other pharmacological properties like anticancer [2] , anti-fungal [3] , antiviral [4] , antitubercular [5] and immunosuppressive effects [6] .
Recently, research projects have been carried out to develop novel anticancer artemisinin-containing compounds, including hybridization of one or more distinct chemical moieties with independent biological modes of action with artemisinin. Many hybrids of artemisinin derivatives with different entities such as podophyllotoxin, cinnamic acid esters, hydroxamic acid, and triazole have been synthesized and demonstrated promising biological activity and enhanced physicochemical properties [4, 7] . It was observed that incorporation of artemisinin and a triazole moiety gave hybrid compounds with improved cytotoxic activity compared with the individual parent compounds [4b, 7a-d, 7i ]. For example, Lee et al. reported the synthesis of 10β-substituted triazoyl artemisinin compound 1 that strongly inhibits the growth of DLD-1, U-87, Hela, SiHa, A172 and B16 cancer cell lines [7a-c] . More recently, Tran and coworkers [7i] confirmed that the combination of hydroxamic acids into the artemisinin skeleton via a triazole linkage, as in 2, exhibited more potent cytotoxic activity against MCF7 breast cancer cells and HL-60 human promyelocytic leukemia cells than DHA. Meanwhile, various 1,2,3-triazolecontaining artemisinin dimers (3) revealed better anticancer activity than artemisinin and 5-fluorouracil [7d].
On the other hand, 3'-azido-3'-deoxythymidine (AZT) has been known as not only an HIV-RT inhibitor, but also as a pronounced anticancer active agent, especially in combination with other antitumor agents such as 5-fluorouracil, cisplatin, paclitaxel, triterpenoids and indenoisoquinolines [8] . Moreover, AZT bears an azide functionality that could be conveniently exploited in its hybridization to other entities via 'click' chemistry. Despite high biological potential, the combination of artemisinin derivatives and AZT into single hybrid molecules has been studied to a rather limited extent up to now. The AZT-DHA hybrids 5 and 6, which were synthesized by covalent linking of AZT and DHA, showed strong antiplasmodial activity comparable with that of DHA, moderate activity against HIV, and was not toxic to HeLa cells [4b].
Considering the documented anticancer activity of the artemisinin scaffold, especially artesunate [9], AZT and functionalized triazole [10] , it is reasonable to suggest that hybridization of artesunate and its derivatives with AZT via a triazole linkage might lead to molecules that exhibit promising cytotoxic activities. Accordingly, in continuation of our interest in pharmacophore hybridization [8d-f], we herein report the synthesis of novel triazole-artemisinin derivative hybrids with AZT and evaluate the influence of the For this purpose, the triazole-linked artesunate-AZT conjugates 10a-e were synthesized following the synthetic procedure illustrated in Scheme 1. Artesunate derivatives 8a-e, prepared from dihydroartemisinin (1), were esterified with propargyl bromide in the presence of Cs 2 CO 3 to give acetylene-functionalized esters 9ae. The subsequent 'click' reaction of AZT and esters 9a-e was carried out in the presence of CuI and N,N-diisopropylethylamine (DIPEA) in THF at room temperature to furnish the triazole-linked target hybrids 10a-e in 57-67% yields.
Analogously, amide triazole-linked artesunate-AZT conjugates 12a-d were obtained via the synthetic procedure shown in Scheme 2 using amide-containing artesunates as coupling partners. The acids 8a,b,d were reacted with either propargyl amine or 3-ethynyl aniline catalyzed by HOBt/EDC in dichloromethane at room temperature for 4-12 h to generate amides 11a-d. The latter amides 11a-d were hybridized with AZT using CuI and DIPEA in THF at room temperature to give target conjugates 12a-d in low yields (< 10%). Meanwhile, using CuI in tert-BuOH at 70 o C, the reaction yields increase to 30-40%.
As part of our ongoing work, the hybridization of artemisinin containing the 2-hydroxypropane unit and triazole was also studied. 3-(10β-(Dihydroartemisinoxy)-1-propylene (13), prepared from dihydroartemisinin (7), was subjected to epoxidation to give 3-(10βdihydroartemisinoxy)propylene oxide (14), which was converted to racemic 1-azido-3-(10β-dihydroartemisinoxy)-2-hydroxypropane (15) by treatment with sodium azide. The subsequent 'click' reaction between compound 15 with propargyl derivatives afforded conjugates 16a-e in 55-66% yields. The chemical structures of the newly synthesized artemisinin hybrids 10a-e, 12a-d and 16a-e were confirmed by means of spectral data ( 1 H NMR, 13 C NMR, IR and MS).
In the next part of this work, the newly prepared compounds were evaluated for cytotoxic activity against two human cancer cell lines (KB, HepG2), and the results are summarized in Table 1 . These results indicated that most of the derivatives possess at least moderate cytotoxic activity and some triazole-artemisinin conjugates displayed a promising activity profile. In particular, four triazole-artemisinin hybrid compounds 10a-c and 16e showed good cytotoxicity against the KB cell line (IC 50 < 25 µM), pointing to the potential interest in this new class of hybrid molecules. Furthermore, compared with the cytotoxicity of amide-triazolelinked artesunate-AZT hybrids with the ester-linked counterparts, it is clear that the nitrogen analogs (hybrids 12b, 12c and 12d) exhibit less potent cytotoxic effects than their corresponding oxygen counterparts (hybrids 10a, 10b and 10d) ( Table 2 ).
In conclusion, sixteen new triazole-artemisinin derivative hybrids were successfully prepared and assessed in terms of their cytotoxic activity in KB and HepG2 cancer cell lines. The results indicated that most of the derivatives exhibit at least moderate to good cytotoxic activities and four representatives displayed a promising potential for further elaboration towards novel anticancer agents. The amide-triazole-linked artesunate-AZT hybrids were less potent than the corresponding ester-triazole-linked analogs.
Experimental
General: All reactions were performed in the appropriate ovendried glassware and under an air atmosphere. Unless otherwise stated, solvents and chemicals were obtained from commercial sources and used without further purification. Column chromatography (CC) was performed using silica gel (60Å, particle size 40-60 µm). NMR spectra were recorded on a Bruker Avance (500 MHz). Chemical shifts (δ) are given in parts per million (ppm) and coupling constants (J) in Hertz (Hz). High resolution mass spectra (HRMS) were recorded on either a Q-exactive or a Q-TOF2 instrument, and IR spectra on a Perkin Elmer Spectrum Two.
Preparation of hybrid compounds 10a-e:
AZT (1 equiv) was added to a solution of propargyl-containing artesunate (9a-e) (1 equiv), DIPEA (12 equiv) and CuI (0.2 equiv) in THF (20 mL). The solution was stirred at room temperature for 3 h. Afterwards, THF was removed under reduced pressure and the residue was extracted with ethyl acetate. The crude products were subjected to CC eluting with 80% ethyl acetate in hexanes to yield compounds 10a-e in 57-67% yield.
Preparation and and cytotoxicity of artemisinin-triazole hybrids Natural Product Communications Vol. 11 (12) 2016 1791 ( 1-((2S,3S,5R)-2-(Hydroxymethyl)-5-(5-methyl-2,4-dioxo-3,4dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3-yl)-1H-1,2,3triazol-4-yl)methyl ((3R,6R,8aS,9R,10S,12R,12aR)-3,6,9-trimethyldecahydro-12H-3,12-epoxy[1,2]dioxepino[4,3 -i]isochromen-10-yl) succinate (10a) MP: 162-163 o C. IR (KBr) cm -1 : 3321, 2928, 2870, 1733, 1706, 1668, 1467, 1362, 1277, 1220, 1148, 1091, 1030, 1018, 877, 841. 1 171.2, 164.1, 150.5, 143.1, 137.5, 124.1, 111.0, 104.5, 92.4, 91.4, 89.6, 87.6, 85.1, 80.1, 60.4, 59.2, 57.8, 51.5, 45.1, 37.6, 37.2, 36.1, 34.0, 31.7, 29.0, 28.7, 25.8, 24.5, 20.1, 12.4, 12.0. HRMS calc. for: C 32 H 44 N 5 O 12 : 690.2981 [M+H] + , Found: 690.2983.
Preparation of compounds 12a-d:
AZT (1.0 equiv) was added to a solution of amide-containing artesunate (11a-d) (1.0 equiv) and CuI (0.1 equiv) in tert-BuOH (20 mL). The solution was stirred and heated to 70 o C for 12 h. The crude products were subjected to CC eluting with 80% ethyl acetate in hexanes to yield compounds 11ad in 30-40% yield.
( 3R,6R,8aS,9R,10S,12R,12aR)-3,6,9-Trimethyldecahydro-12H-3,12-epoxy[1,2]dioxepino[4,3 -i]isochromen-10-yl 5- (((1-((2S,3S,  5R)-2-(hydroxyme-thyl)-5-(5-methyl-2,4-dioxo-3,4 -dihydropyri-midin-1(2H)-yl)tetrahydrofuran-3-yl)-1H-1,2,3-triazol-4-yl)methyl)amino)-5-oxopentanoate (12c) IR (KBr) cm -1 : 3301, 2928, 2850, 1697, 1461, 1549, 1378, 1272, 1217, 1096, 1018, 958, 
Preparation of compounds 16a-e:
1-Azido-3-(10βdihydroartemisinoxy)-2-hydroxypropane (15a-e) (1 equiv) was added to a solution of 3-ethynyl aniline (1 equiv), DIPEA (12 equiv) and CuI (0.2 equiv) in THF (20 mL). The solution was stirred at room temperature for 3 h. The crude products were subjected to CC eluting with 80% ethyl acetate in hexanes to yield compounds 16a-e in 55-65% yield. (4-(3-Aminophenyl)-1H-1,2,3-triazol-1-yl)-3-(((3R,6R,8aS,9R,  10S,12R,12aR)-3,6,9-trimethyldecahydro-12H-3,12-epoxy[1,2] dioxepino[4,3-i]iso-chromen-10-yl)oxy)propan-2-ol (16e) MP: 82-83 o C. IR (KBr) cm -1 : 3357, 2924, 2870, 1702, 1613, 1590, 1488, 1451, 1373, 1227, 1156, 1078, 1043, 1020, 872, 793. 1 7, 146.9, 131.4, 129.8, 121.3, 116.0, 115.0, 112.3, 104.3, 102.7, 88.0, 80.9, 70.0, 69.7, 69.5, 52.5, 44.2, 37.4, 36.3, 34.5, 34.5, 30.8, 26.0, 24.6, 20.3, 13 .0. HRMS calc. for: C 26 H 37 N 4 O 6 : 501.2708 [M+H] + , Found: 501.2711.
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Supplementary data:
Experimental details and the characterization data associated with this article can be found in the online version.
